Life Science Development Projects Position Baltimore BioMed Ecosystem for Boom

Published on :

The Baltimore biotech ecosystem is thriving. And new, big and bold life sciences development projects are in the works, leading many to project Charm City as the next sector of the BioHealth Capital Region (BHCR) to boom.

Longtime FastForward Startup’s Acquisition Caps Founder’s Entrepreneurial Journey

Published on :

Dozens of startups have called FastForward’s innovation hub in the 1812 Ashland building home since it opened five years ago. Now, one of the original tenants will be moving out for a good reason.
Avidea Technologies, which develops T cell immunotherapies to treat cancer and autoimmune diseases, was acquired by Vaccitech, a British drug and vaccine maker, in December 2021 for $40 million. The deal was the culmination of a lifetime of research and more recent entrepreneurial efforts by Geoffrey Lynn, Avidea’s co-founder and CEO, who attended the Johns Hopkins University School of Medicine.
“Avidea was really the vehicle for our team to advance promising therapies to patients,” he says. “From our earliest days, we always kept an open mind about how to achieve this and how we would eventually exit the company.”

Johns Hopkins Technology Ventures Boosts Maryland Life Sciences

Published on :

Johns Hopkins Technology Ventures (JHTV) has had a significant impact on the Maryland life sciences ecosystem since its founding in 2014, assisting with hundreds of licensed therapeutics in development and backing nearly 200 startups that have collectively nearly $3 billion in venture capital funding, 30% of which has remained in the state.

Aaron Chang, Renalert CEO – Engineering a Global Paradigm Shift to Prevent Acute Kidney Injury

Published on :

In Conversation with Aaron Chang, CEO of Renalert – Engineering a Global Paradigm Shift to Prevent Acute Kidney Injury Every entrepreneur has a “founder’s story” that serves to build the unique [….]